Aldo-keto reductase family 1 member B1 pseudogene 7 (AKR1B1P7)

Aldo-keto reductase family 1 member B1 pseudogene 7 (AKR1B1P7) is a human pseudogene identified on chromosome 19. It is classified as a processed pseudogene and does not encode a functional protein. There is no evidence supporting a role for AKR1B1P7 in biological processes, disease mechanisms, or as a drug target. This distinguishes AKR1B1P7 from related functional aldo-keto reductase family genes, which are involved in a variety of metabolic processes. Reporting AKR1B1P7 as a molecular target for drugs or therapies would be incorrect, as it lacks functional activity and does not participate directly in cellular pathways relevant to pharmacology or disease intervention[1][6][9]. There is published literature that establishes functional regulatory roles for some pseudogenes—for example, *AKR1B10P1* in cancer—but AKR1B1P7 is *not* among those with experimentally demonstrated effects on cellular pathways or disease states[2][9]. The conventions and scientific consensus do not consider AKR1B1P7 as a therapeutic target or actionable molecule.

Other names

AKR1B1P7HGNC: 33497NCBI Gene: 126242Ensembl: ENSG00000266899Previous GeneCards identifiers: GC19M038544GC19M033851

None; as a pseudogene, it is not a functional drug target.